NEWSpublisher 2007 :: AngloChinese Investments » Company news » ChemWerth, Inc. announces Wuhan Pharmaceutical Factory passes FDA inspection

	23/07/2009 [Company watch] China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products

	15/03/2010 [Industry news] Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China

	26/10/2009 [Finance] China Growth to Remain Fast in Fourth Quarter, Official Says

	17/08/2009 [Industry news] Chindex Posts Profit on Product Sales, Health Services

	07/05/2010 [Industry news] Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd

COMPANY NEWS

02/07/2009 [Industry news]
ChemWerth, Inc. announces Wuhan Pharmaceutical Factory passes FDA inspection

02 Jul 2009 - ChemWerth Inc. reported the Wuhan Pharmaceutical Factory facility has passed an FDA overseas inspection with a two point 483 being issued.

ChemWerth Inc. reported the Wuhan Pharmaceutical Factory facility has passed an FDA overseas inspection with a two point 483 being issued. ChemWerth and Wuhan are collaborating to develop APIs for the U.S. and other regulated markets overseas. Wuhan continues to be a primary supplier of high quality Active Pharmaceutical Ingredients to the Chinese and U.S. markets. According to Mr. Peter Werth, CEO: ChemWerth has been working with the FDA in China for over 25 years and has been through approximately 100 FDA inspections. Our regulatory expertise in helping manufactures like Wuhan get approved is a real value-added benefit for our customers. We’re proud to have Wuhan as a manufacturing partner.

Home | Company news | TOP 50 | Events | About us